Nike is raising prices on a range of merchandise as it braces for tariffs to hit its profits and tries to carry out a ...

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

AstraZeneca AZN stock has declined 6.4% in the past three months. Although AstraZeneca faces its share of challenges, a ...

Amgen’s AMGN stock has declined 10.4% in the past three months. A lot of this price decline is related to the broader ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many patients in ...